Embecta +€0.3 +2.42% Today
1D 1W 1M 3M 1Y 5Y
4.33 % Dividend Yield
17 Dec Expected
This list is based on the watchlists of people on Stock Events who follow JX7.F. It's not an investment recommendation.
This list is an analysis based on recent market events. It's not an investment recommendation.
Medtronic
MDT
Mkt Cap 113.61B
Medtronic is a major player in the medical devices sector, directly competing with Embecta in the diabetes management space, including insulin pumps and glucose monitoring systems. Abbott Laboratories
ABT
Mkt Cap 197.08B
Abbott Laboratories offers a wide range of medical devices, diagnostics, and nutritional products, competing with Embecta in areas such as glucose monitoring.
DexCom specializes in continuous glucose monitoring (CGM) systems, a direct competitor to Embecta's diabetes care products. Tandem Diabetes Care
TNDM
Mkt Cap 2.85B
Tandem Diabetes Care is a direct competitor in the insulin pump market, offering advanced diabetes management systems.
Insulet Corporation specializes in tubeless insulin pump technology, competing in the insulin delivery market alongside Embecta. Novo Nordisk
NVO
Mkt Cap 620.4B
Novo Nordisk is a global healthcare company with a strong focus on diabetes care, including insulin and devices, competing with Embecta's offerings.
Sanofi is involved in diabetes care through its insulin and glucose monitoring products, making it a competitor to Embecta. Bristol-Myers Squibb
BMY
Mkt Cap 101.27B
Bristol Myers Squibb, through its acquisition of MyoKardia, has expanded into various healthcare sectors, potentially competing with Embecta in the broader medical devices and healthcare market. Johnson & Johnson
JNJ
Mkt Cap 399.26B
Johnson & Johnson, through its medical devices segment, competes in the healthcare market, including areas that overlap with Embecta's diabetes care products. Boston Scientific
BSX
Mkt Cap 120.45B
Boston Scientific Corporation operates in the medical devices sector, competing in various areas that could intersect with Embecta's market, including diabetes care solutions.
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.
Show more...